Evidence map›Paper›PMID 27381400›Full record

ArticleAntimicrobial agents and chemotherapy2016

The DNA Polymerase Gamma R953C Mutant Is Associated with Antiretroviral Therapy-Induced Mitochondrial Toxicity.

Min Li, Andrea C Mislak, Yram Foli, Esinam Agbosu, Vivek Bose, Shreya Bhandari, Michal R Szymanski, Christie K Shumate, Y Whitney Yin, Karen S Anderson and 1 more

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Min LiDepartment of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA.
Andrea C MislakDepartment of Pharmacology, Yale School of Medicine, New Haven, Connecticut, USA.
Yram FoliDepartment of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA.
Esinam AgbosuDepartment of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA.
Vivek BoseDepartment of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA.
Shreya BhandariDepartment of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA.
Michal R SzymanskiDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, USA.
Christie K ShumateDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, USA.
Y Whitney YinDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, USA ywyin@utmb.edu karen.anderson@yale.edu elijah.paintsil@yale.edu.
Karen S AndersonDepartment of Pharmacology, Yale School of Medicine, New Haven, Connecticut, USA ywyin@utmb.edu karen.anderson@yale.edu elijah.paintsil@yale.edu.
Elijah PaintsilDepartment of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA Department of Pharmacology, Yale School of Medicine, New Haven, Connecticut, USA Department of Epidemiology & Public Health, Yale School of Medicine, New Haven, Connecticut, USA ywyin@utmb.edu karen.anderson@yale.edu elijah.paintsil@yale.edu.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
MECHANISM AND INHIBITION OF HIV REVERSE TRANSCRIPTASER01GM049551 · NIGMS · YALE UNIVERSITY · PI ANDERSON, KAREN S. · 1993 to 2019
$9.0M
INSTITUTIONAL NATIONAL RESEARCH SERVICE AWARDT32GM007324 · NIGMS · YALE UNIVERSITY · PI BENNETT, ANTON M · 1987 to 2022
$6.2M
Structural Basis for Antiviral Drug Mitochondrial ToxicityR01AI134611 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI YIN, YUHUI · 2018 to 2022
$2.0M
Dissecting Dual Function of Pol gamma in mtDNA Replication and Oxidative Damage RepairR01GM110591 · NIGMS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI YIN, YUHUI · 2014 to 2018
$1.3M
Studies of toxicities of HIV RT inhibitors to human mitochondrial DNA polymeraseR01GM083703 · NIGMS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI YIN, YUHUI · 2008 to 2012
$1.3M
HIV Nucleoside Analogs Translational Studies: Resistance and MetabolismK08AI074404 · NIAID · YALE UNIVERSITY · PI PAINTSIL, ELIJAH · 2008 to 2012
$629k
Human PrimPol: A Novel Mechanism of Antiviral ToxicityF31AI116322 · NIAID · YALE UNIVERSITY · PI MISLAK, ANDREA · 2015 to 2015
$37k
NCATS NIH HHS UL1 TR001863NIAID NIH HHS F31 AI116322NIAID NIH HHS K08 AI074404NIAID NIH HHS R01 AI134611NIGMS NIH HHS R01 GM049551NIGMS NIH HHS R01 GM083703NIGMS NIH HHS R01 GM110591NIGMS NIH HHS T32 GM007324
6 · The paper itself

Abstract

We found a heterozygous C2857T mutation (R953C) in polymerase gamma (Pol-γ) in an HIV-infected patient with mitochondrial toxicity. The R953C Pol-γ mutant binding affinity for dCTP is 8-fold less than that of the wild type. The R953C mutant shows a 4-fold decrease in discrimination of analog nucleotides relative to the wild type. R953 is located on the "O-helix" that forms the substrate deoxynucleoside triphosphate (dNTP) binding site; the interactions of R953 with E1056 and Y986 may stabilize the O-helix and affect polymerase activity.

Indexed as

Amino Acid SequenceAnti-Retroviral AgentsBinding SitesDNA-Directed DNA PolymeraseDNA Polymerase gammaFemaleHIV InfectionsHumansMaleMiddle AgedMitochondriaMutationProtein ConformationAnti-Retroviral AgentsDNA-Directed DNA PolymeraseDNA Polymerase gamma

Identifiers

PMID27381400
PMCPMC4997837

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.